Protein Enriched Microvesicles and Methods of Making and Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/872,115, filed Aug 30, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,643,635 | Protein Enriched Microvesicles and Methods of Making and Using the Same In force · High confidence UsedRemaining | Takara Bio USA, Inc. | In force | High confidence | ||
| US 12,319,934 | Protein Enriched Microvesicles and Methods of Making and Using the Same In force · High confidence | Takara Bio USA, Inc. | In force | High confidence | ||
| US 9,593,356 | Protein Enriched Microvesicles and Methods of Making and Using the Same In force · High confidence | Takara Bio USA, Inc. | In force | High confidence | ||
| US 10,793,828 | Protein Enriched Microvesicles and Methods of Making and Using the Same In force · High confidence | Takara Bio USA, Inc. | In force | High confidence | ||
| Application 14/737,423 | Protein Enriched Microvesicles and Methods of Making and Using the Same Abandoned Abandoned Mar 12, 2018 | Takara Bio USA, Inc. | Abandoned | Abandoned Mar 12, 2018 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Takara Bio Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.